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Abstract 
The question is examined, "Are there risk factors associated with ophthalmic medications and 
breastfeeding?" And, are optometrists are really aware of such risks? A survey of 306 
optometrists revealed that approximately one third of optometrists were unsure that ophthalmic 
drugs are passed into breast milk. In a parallel fashion, this study probed the general awareness 
and current practices with ophthalmic drugs and nursing women to determine if proper informed 
consent procedures are occurring before instilling ophthalmic drugs with nursing mother patients. 
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INTRODUCTION: 
There is very little optometric literature on systemic effects of ophthalmic drugs and nursing 
mothers. Some textbooks may state "caution" or "avoid". Some ophthalmology journals relay 
more specific but still limited information. Consequently, the average optometrist is simply not 
exposed to the details of these issues in optometry school or in continuing education courses. 
The limited discussion of ophthalmic drugs passing into breast milk leads to the question 
whether optometrists believe there is any risk. And whether they believe there is a risk will in 
turn effect their decisions in obtaining informed consent from nursing mothers. How are 
optometrists handling these issues in their practices? A survey involving 306 optometrists 
investigated the issues of general awareness and general practices of ophthalmic drugs and the 
nursing mother. 
There are many variables involving the excretion of drugs into breast milk such as, "milk 
composition, suckling pattern, pharmacologic properties of the drug, pH of the milk, its fat/water 
content, and relation of suckling to dosing". 1 Samples and Meyers states that, " ... with few 
exceptions, all drugs that are present in the maternal circulation are transferred into milk. "2 We 
know that ophthalmic drugs are passed into systemic circulation of varying amounts - with 
variables such as the specific composition of the ophthalmic drug, whether punctal occlusion was 
performed, or the amount of drops used, etc. 
Several sources suggest caution with ophthalmic drugs and nursing mothers. Lustgarten and 
Podos3 wrote an article in 1983 on "Topical Timolol and the Nursing Mother". Their 
conclusions were that timolol should be used with caution in the case of nursing mothers. Their 
results prompted " ... the manufacturer to revise their listing in the Physician's Desk Reference to 
include an advisory to nursing mothers." They also reference Williams and Ginther's 1982 
article on "Hazards of ophthalmic timolol" that reported a case of an 18-month-old who had 
several spells of apnea, " ... a side effect not yet noted in adults even with use for systemic 
effect." and such the second reported case of apnea in children. It is suggested that infants 
should be observed carefully for signs ofbeta-blockade2 if the mother is using topical ophthalmic 
timolol such that it is actually concentrated in breast milk.4 A beta-adrenergic antagonist had 
produced milk levels of approximately six times the serum levels.4 Situations such as if the infant 
has impaired renal function should be best advised to considerations, for example, having the 
child weaned. 2'4 Ultimately, Pilocarpine is recommended over beta-adrenergic antagonists or 
carbonic anhydrase inhibitors.2 Another common ophthalmic medication is sodium fluorescein. 
Mattern & Mayer suggest that fluorescein has a low potential for toxicity and that nursing 
mothers should be notified to not breast feed for 8-12 hours after topical fluorescein 
administration. 5 As for a carbonic anhydrase inhibitor, again the physician is advised to suggest 
weaning if the infant has impaired renal or hepatic or respiratory function if the mother is taking 
acetazolamide.2 Its excretion into breast milk was found and quantified. 6 Another ophthalmic 
medication commonly used in clinics is addressed by Samples and Meyer in "Use of Ophthalmic 
Medications in Pregnant and Nursing Women", who note that phenylephrine may be 
contraindicated in nursing women due to the risk of precipitating severe hypertension.2 A web 
site, another vehicle of information being used by many professionals, states that it is not 
recommended in breast feeding. 7 Also suggested to probably avoid is ophthalmic 
corticosteroids. There is a lack of data available on topical use and the data shows that with 
systemic use corticosteroids can cause other adverse effects such as suppression of growth and 
interference of endogenous production.2 Although the risk of ophthalmic antiviral agents may be 
unlikely to be excreted in human milk it is still suggested to not prescribe the medication unless 
the benefits outweight the potential risks such due to the potential for tumorigenicity found in 
animal studies.2 
Clearly there are some risk factors associated with ophthalmic medications and breast-feeding. It 
is less clear if practitioners are really aware of such risks. Optometrists can only weigh the 
benefits-to-risks, and counsel their patient on options such as pumping breastmilk or weaning if 
they are aware that the patient is nursing. We simply need to know if our patients are breast-
feeding to simply provide proper informed consent. 
The current optometrist may wonder, how likely will my patient be breast-feeding. Trends of 
mothers breast feeding have had their up and down swings, from the late 1930s when 77% of 
mothers in the USA were nursing to the downward trend in the 1970s of 28% when formula 
companies hit hard. 8 This rapid decline became a concern for many and thus in the 1970s there 
was an increased concern to promote, support and encourage breast feeding thus increasing the 
number to 58% in the 1980's. 8 By 1983 the incidence of in-hospital breast feeding was 65-71% 
in the western world.9 Currently, there is an increased push for mothers to be breast feeding . 
Public health experts are promoting this and formula companies are backing off and providing a 
supportive role stating that "Breast is Best". Reported in 1998, approximately 44 percent of 
infants in the developing world are exclusively breastfed. 10 The US Public Health Services had 
set a goal for the year 2000 such that 75% of mothers being discharged at the hospital will be 
breast feeding. ' '· 12 Hospitals are providing better support and having lactation consultants 
available for new mothers to promote breast feeding. Many other organizations such as La Leche 
League, World Health Assembly, National Alliance for Breast feeding Advocacy (NABA), all 
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promote and support breast feeding. WHO, World Health Organization, is even suggesting to 
breast feed till at least age two. With an increase of support and encouragement for new mothers 
to breast feed, there will be an increase in mothers who will be in our chair. 
The current day optometrist may not be thinking of breastfeeding issues as perhaps they may 
feel that it is far from their realm of interest. Surprisingly, benefits ofbreastmilk also touch the 
area of optometry as well of other health professionals. There is a lot of research that is looking 
at the benefits of breast feeding. Some research is showing that there is a significant difference in 
cognitive13 and intellectual development14 between breast-fed and formula fed babies- with 
breast-fed babies coming significantly ahead. Optometrists should be aware of the research that 
is showing that infants who are fed breast milk have better visual-evoked potential acuity. This 
had a positive correlation with docosahexaenoic acid (DHA), an omega-3 fatty acid that is 
absence from infant formula. 15 Other studies determined that omega-3 essential fatty acid (EFA) 
has a positive influence on visual development. 16• 14 At 57 weeks (4 months) the breast fed 
babies had significantly better visual evoked potential and forced choice preferential-looking 
acuity than formula fed babies. 16 At 36 months, these breast-fed children had significantly better 
random dot stereo acuity and letter matching ability than formula fed babies. 16 The benefits of 
breast feeding again becomes an issue involving optometry and here is an opportunity for 
mothers to give their infants a head start, visually. 
With optometrists gaining increased TP A privileges across the country, we will be under the 
scrutiny of the public and other professionals. Whether or not other professionals ask their 
patients every time if they are nursing, we need to consider the legal and ethical consequences 
and ramifications for ourselves and our profession. Optometrists have made it through many 
milestones to have the privileges we have today- from the first law in 1971 to authorize the use 
of ophthalmic agents for diagnostic purposes17 to the present of optometrists having TPA 
privileges. The future holds more responsibility such as optometrists having the authority to 
prescribe oral medication. As the trend continues, optometrists will be scrutinized and thus need 
to be prudent in their method of consent and history taking before administering any medication, 
whether ophthalmic, topical or oral. 
Ultimately, with the privilege of using ophthalmic agents, comes the responsibility for proper 
patient consent with patient care. Optometrists are being held to a standard of care expected of 
other health care professionals. Classe comments that, "Failure to adhere to the prevailing 
standard of care expected of optometrists under the circumstances would result in liability for 
damages legally caused by such conduct. This is the rule that prevails today throughout the 
United States for negligence claims against optometrists."18 We need to continue to be prudent for 
our patients, ourselves, and our profession. This study was undertaken as an awareness check 
on these concerns. 
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METHODS 
The sample consisted of 1500 optometrists across the United States. Names were obtained from 
a random sample of optometrists maintained by the Division of Continuing Education at Pacific 
University. A total of 306 surveys were returned and entered into File Maker Pro to obtain the 
results. The main goal of the survey was to determine the level of awareness of optometrists 
involving issues of nursing patients and ophthalmic drugs. Issues within this scope were to 
determine the awareness of potential risks; determine what is being asked in the office; determine 
the knowledge of potential excretion of drugs in breast milk; and determine the level of 
responsibility on doctor vs. patient. Please see sample survey in Appendix. 
RESULTS 
Ofthe 306 optometrists, 96.73% were TPA certified. The ratio of female to male optometrists 
was 66.66% being male and 33.33% being female. The majority of male optometrists were 
between the ages of 40-49YO (41.18% of male sample) and between the ages of30-39YO 
(31.3 7% of male sample). The majority of female optometrists were between the ages of 30-
39YO (68.63%). See Figure!. 
Awareness of risks associated with ophthalmic drugs and nursing vs. pregnancy showed that 
optometrists are more unsure of the risks when it comes to nursing. There were 24.59% who 
noted "I'm not sure" to the risks with nursing mothers as compared to 16.99% optometrists who 
noted "I'm not sure" to the risks with pregnancy. See Figure 2. When comparing the responses 
between female and male optometrists, females demonstrated a greater uncertainty to knowing 
the risks associated with nursing and pregnancy. Male optometrists showed an 80.88% 
response to knowing there were risks associated with pregnancy yet 73.53% of female 
optometrists knew the risks associated with pregnancy. See Figure 3. Again male optometrists 
showed a 75.49% response to knowing there were risks associated with nursing and 62.75% of 
female optometrists knew the risks associated with nursing. See Figure 4. A continued 
uncertainty is shown with 38.24% of female optometrists unsure that ophthalmic drugs pass 
into breast milk and a 32.84% of male optometrists with similar uncertainty. See Figure 5. 
Optometrists were also asked to rate the risk of using specific ophthalmic drugs for nursing 
mothers. Some trends showed that a majority of optometrists rated proparacaine and polymyxin 
Bas being probably safe. Tetracycline, Acetazolamide, Atropine and Prednisolone were noted 
by a m~ority as to avoid. The greatest uncertainty was towards the risks associated with 
Acetazolamine and Timolol. See Figure 6. 
When asked who is responsible for establishing that the patient is nursing, the optometrists 
surveyed expressed that it is primarily the doctor's responsibility- 55.44% of male optometrists 
and 44.00% of female optometrists. A larger discrepancy between male and female 
optometrists' views showed that 33.00% female optometrists were more likely to believe that it 
is primarily the patient's responsibility while 20.73% of male optometrists believed the same. 
See Figure 7. 
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Figure 2 Awareness of the risks of ophthalmic drugs on NURSING women vs. PREGNANT women 
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Figure 4 Awareness of risk factors associated with ophthalmic drugs and NURSING - comparing 
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Figure 5 Awareness of ophthalmic drugs passing into breastmilk - comparing male and female 
I'm not sure 
13.92% 
No, I know there are not 
1.47% 
Yes, I know there are 
optometrists 
I [ l ,~---· I -
: I 
i I I I 38.24% 
~ ~ ·""""""--~ I 
32.84% I 
l 
I 
61.27% 
0 female (n=1 02) I 
male (n=204) 
-0 
Figure 6 How Optometrists rate risk factors of specific ophthalmic drugs for NURSING mothers 
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There is a larger difference between whether the optometrist is asking their patient if they are 
pregnant or nursing. The survey found that 50.99% of optometrists ask their patients every 
time if they are pregnant vs. only 30.36% of optometrists are asking their patients if they are 
nursing. See Figure 8. When looking at whether optometrists are asking their patients if they are 
pregnant before instilling ophthalmic drugs- 21.57% female optometrists and 17.33% male 
optometrists are "not" asking this question before instilling ophthalmic drugs. See Figure 9. Yet 
when the same questions is in regards to nursing- a much bigger discrepancy is noted- 37.25% 
female and 35.00% male optometrists are not asking. See Figure 10. 
When asked the main reasons why optometrists do not ask their patients if they are nursing, the 
results were the following- 35% "other reasons", 24% "not relevant", 21% "patient is 
responsible", 10% "uncomfortable to ask", 10% "no answer". See Figure 11. Female 
optometrists's reasons primarily consisted of32.88% being "other" and 27:0% being "the 
patient is responsible" while male optometrists' reasons primarily consisted of 3 7. 58% being 
"other" and 24.16% being "not relevant". See Figure 12. 
Commonalities were found in the reasons why optometrists are not asking their patients if they 
are nursing - 31% said that they haven't given it much thought, 16% said that the ophthamic 
drugs they use are "safe", 14% feel it is covered by the history form, 12% feel that they should 
or will add it to their form, 12% won't ask since the patient may not be of childbearing age, 11% 
assume that the patient is not nursing if they don't have a child with them, 4% feels that the 
patient usually tells them. See Figure 13. 
The survey also probed the reasons optometrists are asking if their patient is nursing - the top 
three reasons were: 41% would if the patient has recently given birth; 21% if when the patient 
brings a young child to the office, 14% if they are going to prescribe medication. See Figure 14. 
Age groups when optometrists do ask their patients if they are nursing - 61% ask patients of 
ages 20-35YO, 51% ask of those 36-44YO, 14% ask of those 16-19YO, 8% ask of those 46-
60YO. See Figure 15. 
Of those optometrists who are "not sure" if ophthalmic drugs are a risk to nursing mothers, 
61.33% do not ask their female patients if they are nursing while 16% do ask every time. See 
Figure 16. Again of those optometrists who are "not sure" if ophthalmic drugs pass into 
breastmilk, 59.43% do not ask their female patients if they are nursing while 16.04% do ask 
every time. See Figure 17. 
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Figure 11 Main reasons why optometrists are not always asking their patients if they are nursing 
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figure 12 Reasons why optometrists are NOT always asking their female patients if they are 
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Figure 13 The reasons optometrists are NOT always asking if their patient are NURSING {multiple 
responses allowed) 
Usually the patient tells me 
I should/1'11 add it to the form 
12% 
If the patient doesn't have a 
child with them 
11% 
If the patient is not of child-
bearing age 
12% 
4% 
It's covered by the history 
form 
14% 
Haven't given it much 
thought 
I use safe drugs 
16% 
31% 
-\0 
Figure 14 The reasons optometrists are SOMETIMES asking if their patient are NURSING (multiple 
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Figure 15 Age groups in which optometrists do ask their patients if they are nursing (multiple 
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Figure 16 Of those optometrists who are "not surell if ophthalmic drugs pass into breastmilk, are 
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Figure 17 Of those optometrists who are "not sure" if ophthalmic drugs are a risk to NURSING 
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DISCUSSION 
The question 
Should optometrists ask their patients whether they are nursing before instilling ANY 
ophthalmic drugs? The answer should be based on a simple argument of standard of care. 
Unfortunately, this response may be an oversimplified argument due to a web of secondary 
ISSUeS. 
The Issues 
Several issues seem to be involved: 
1. Whose responsibility is it to bring up the topic of nursing during the exam - is the onus on the 
doctor or patient? 
2. What assumptions are being made on the issue of consent? 
3. Does the optometrist believe that there are any risks to the nursing mother and child with any 
ophthalmic drugs? 
4. What assumptions - on the part of the doctor or patient - are being made about the risk of 
ophthalmic drugs? 
l.The Responsibility 
The question is simple, during the optometric exam, is the onus of responsibility on the doctor or 
the patient to bring up the risks of ophthalmic drugs passing into breast milk? Is it the doctor's 
responsibility to flag the patient that ophthalmic drugs are absorbed systemically and do pass 
into breast milk? Is it the patient's responsibility to know that eye drops pass into their breast 
milk? 
The survey showed that 55.44% of male optometrists and 44.00% of female optometrists feel 
that it is primarily the doctor's responsibility to establish the patient is nursing. Thus, if it is the 
optometrist's duty to inform- then by what means will she ask? By simply verbally asking, or 
via a history questionnaire, or by their pretester/assistant? No matter what method the 
optometrist chooses it is their responsibility to obtain this information appropriately as they 
themselves have the license to instill the ophthalmic drugs. 
This study demonstrates that 3 3. 00% female optometrists and 20.73% of male optometrists 
believed that it is primarily the patient's responsibility to establish that they are nursing. If it is 
the patient's duty to inform - then is the patient comfortable sharing their status of nursing with 
their eye care practitioner? Does the patient even understand that ophthalmic drugs can be 
absorbed systemically and thus absorbed in breast milk? Does the patient assume that their 
doctor will ask appropriate questions if there are any concerns relating to general systemic 
health? 
The problem of promoting that it is the patient's responsibility to inform their doctor is simply 
too unrealistic. The survey demonstrated 38.24% of female optometrists were unsure that 
ophthalmic drugs pass into breastmilk and 32.84% of male optometrists are also uncertain. If 
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optometrists do not universally understand that ophthalmic drugs are excreted in breast milk -
how can one assume that a non medical person, thus the patient, would understand it either. 
An analogy can be made in regards to topical glaucoma medication and its systemic side effects. 
How is a patient to know that a topical glaucoma medication could cause impotence? It may be 
difficult for the patient to equate an eye drop to their sexual drive. It is again the responsibility 
of the optometrists to provide a complete understanding of the side effects of the medications we 
prescribe- thus understand the systemic health condition of our patient. We simply can not 
expect our patients to hold the same amount of knowledge and experience as their optometrist. 
2.Issue of Consent 
Consent is so important before any procedure, whether checking intraocular pressures with 
Goldman applanation tonometry or whether checking a health history before instilling drops. No 
matter what, a patient is coming to seek the expertise of their eye care practitioner and thus it is 
the duty of the optometrist to provide that care on every level. 
The study demonstrated that only 30.36% of optometrists ask their patients everytime if they 
are nursing. If an optometrist doesn't even ask a women if she is nursing - then there is no 
complete consent before instilling drops as the optometrist doesn't even know the situation. 
Thus the optometrist is unable to discuss options. There are many - punctal occlusion, delay of 
breast feeding or pumping within a specific period of time after instillation of drops, discussion 
of pros and cons, or delay or postponement of treatment. By not asking the optometrist is 
robbing the patient of choices and options which that patient is obliged to have. Ultimately it is 
the patient's decision to participate in a procedure once they understand the risks and benefits-
this is a ethical responsibility of the optometrist to present for the patient. 
In addition to moral and ethical responsibility to the patient, there is the responsibility to 
provide the proper consent that is legally required of the optometrist. Proper consent is simply 
not obtained if poor history taking is occurring. 
3 .Assumptions 
If assumptions are being made on the optometrists' side, there will no doubt be an increase of 
poor communication and thus ultimately a breakdown of the quality of care that is provided. 
When asked in the survey of the main reasons why optometrists are not always asking their 
. patients if they are nursing, the results were as follows: 35% "other reasons", 24% "not 
relevant", 21% "patient is responsible", 10% "uncomfortable to ask". Within the 35% of other 
reasons - the most common reason was that 31% said that they "haven't given it much thought". 
These are eye opening responses that demonstrate the need for optometrists to understand 
issues of breast-feeding and ophthalmic drugs. To express that they haven't given it much 
thought and that it is not relevant, demonstrates the lack of knowledge that is in the profession 
towards issues of the nursing patient. To express that it is the patient's responsibility and that 
they are uncomfortable to ask demonstrates a need for a new look of our responsibility as 
doctors. The optometrist's scope today is not limited to the eyes, we are trained in 
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understanding systemic conditions. We need to feel comfortable to discuss our patient's 
systemic conditions so that we can provide superior care. 
Other assumptions were discovered in this study. The survey probed the reasons why 
optometrists are" sometimes" asking if their patient is nursing before instilling any ophthalmic 
drugs - the top two reasons were: 41% would if the patient has recently given birth, 21% if 
when the patient brings a young child to the office. With the first assumption being that the 
patient has recently given birth - what defines recent; one month, three months? How is the 
optometrist to know that a recent birth has occurred? Perhaps patients will tell their optometrist 
but perhaps they won't. Other thoughts may be perhaps on how the patient looks physically, 
which can be very deceiving. The other assumptions that a new mother will bring in her child is 
also poor reasoning. A new mother may be leaving her child with the new dad, other family 
members or friends or their child care provider. 
Another factor that is influencing the optometrist is based on the patients' age. This may be a 
logical and gut reaction judgement call. Yet the results show that optometrists ask 61% patients 
of ages 20-35YO, 51% of36-45YO, 14% of 16-19YO, 8% of 46-60YO. One issue is that those 
patients between 16-19 Y 0 may be even less likely to first tell their optometrist of their recent 
delivery and with only 14% of optometrists including this age group in their questioning leads to 
increased chance of poor informed consent. 
It was eye opening to see if there were any differences or similarities between how female and 
male optometrists handle the issue of nursing patients. The study revealed that female 
optometrists were actually placing a larger responsibility on the patient for acknowledging if the 
patient is nursing. It showed that 33.00% female optometrists were more likely to believe that 
it is primarily the patient's responsibility while 20.73% of male optometrists believed it was 
primarily the patient's responsibility. Again male optometrists showed a 75.49% response to 
knowing there were risks associated with nursing and yet a lower response of 62.75% for female 
optometrists. It should be noted that male optometrists in this survey had longer lengths of 
careers. Perhaps this is not a gender issue but and issue of experience. Further study is required 
to fully understand these issues. 
Concluding Statement 
With any ophthalmic medication and with any patient, including the nursing mother, the benefit-
to-risk ratio needs to be weighed. In order to effectively weigh this, there simply needs to be 
proper informed consent to discuss the advantages and disadvantages of initiating treatment. 
There needs to be proper informed consent to discuss the options available tothe patient- to 
begin treatment, to delay treatment, to wean the infant, to pump breast milk until treatment is 
finished, to accept the risks. Ultimately it is the doctor's responsibility to initiate the necessary 
questioning to thus provide proper patient care. The patient should not have to take the role of 
the practitioner in understanding the risks, the optometrist needs to know and then explain the 
risks. 
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APPENDIX 
A Pacific University College of Optometry student is writing a thesis on ophthalmic drugs, 
and patients who are nursing or pregnant. We would appreciate your assistance in filling out this survey. 
I. General Awareness 
1. To your knowledge, are there possible risk factors associated with ophthalmic drugs and PREGNANCY? 
DYes, I know there are ONo, I know there are none OI'rn not sure 
2. To your knowledge, are there possible risk factors associated with ophthalmic drugs and NURSING? 
DYes, I know there are ONo, I know there are none Dl'rn not sure 
3. To your knowledge, can any ophthalmic drug pass into breasbnilk? 
DYes, I know it can 0 No, I know it cannot 0 I' rn not sure 
4. Please rate the risk factor of the following drugs for nursing moms: 
Avoid Use caution Probably safe Don't know 
Tetracycline 
Timolol 
Acetazolamide 
Proparacaine 
Atropine 
Cyclopentolate 
Prednisolone 
Sulfonamides 
Polymyxin B 
II. Practices 
0 0 0 0 
0 0 0 0 
0 0 0 D 
0 0 0 0 
o o D D ~ 
0 0 D D 
0 0 D D 
0 0 0 D 
0 0 0 D 
1. Do you ask your female patients if they are PREGNANT before instilling ophthalmic drugs? 
DYes, every time DSometimes DNo, I don't ask 
If "sometimes", when: 
2. Do you ask your female patients if they are NURSING before instilling any ophthalmic drugs? 
DYes, every time DSometimes DNo, I don't ask 
If" sometimes", when: 
3. If you ask any patients if they're NURSING, of which age groups? (please check ALL that apply) 
D10 -15 016-19 D20 -35 D36 -45 D46- 60 Oover60 
4. If you are not always asking women if they are NURSING, what's the main reason? (check ONE only) 
D I'm uncomfortable to ask D I don't think it's relevant D It's their responsibility to tell me 
Oother: 
5. Who is responsible for determining if the patient is nursing? 
D It's COMPLETELY the doctor's responsibility D It's PRIMARILY the doctor's responsibility 
D It's PRIMARILY the patient's responsibility 0 It's COMPLETELY the patient's responsibility 
Ill. Personal Background 
1. How long have you been practicing optometry? 
D0-5 ye~s D6-10 years Dll-20 years Dmore than20 years 
2. What is your gender? Dmale Dfemale 
3. What is your approximate age? 
D under 30 0 30 - 39 years D 40 - 49 years D 50 -59 years 0 60 or older 
4. Do you have current TPA prescribing privileges? DYes DNo 
THANK YOU. For questions about the survey, please contact Neena Gabrielle at gabrieln@pacificu.edu 
